Phase I study of flutamide, a nonsteroidal antiandrogen, in patients with prostatic cancer
A phase I study of orally administered flutamide (a pure anti-androgen) was performed in 26 patients with prostatic cancer. No side effects were observed in 11 patients receiving single doses of either 125, 250, 375 or 500 mg. However, in the daily dosing schedule of 375, 750, 1125 and 1,500 mg/day...
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 39(1993), 4 vom: 15. Apr., Seite 381-9 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , , , , |
| Format: | Aufsatz |
| Sprache: | Japanese |
| Veröffentlicht: |
1993
|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica |
| Schlagworte: | Clinical Trial Clinical Trial, Phase I Controlled Clinical Trial English Abstract Journal Article Multicenter Study Dihydrotestosterone 08J2K08A3Y Testosterone 3XMK78S47O mehr... |